Contact this trialFirst, we need to learn more about you.
CLE-100 for Treatment of Major Depressive Disorder
Recruiting0 awardsPhase 2
Dearborn Heights, Michigan
This trial will test whether the study drug CLE-100 is effective in treating Major Depressive Disorder in patients who are already taking antidepressant medication. The trial is double-blind, meaning neither the patients nor the doctors will know who is receiving the study drug and who is receiving the placebo. The trial is also randomized, meaning that patients will be assigned to either the study drug or the placebo group by chance.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.